Evidence map›Paper›PMID 23881354›Full record

ArticleMucosal immunology2014

Central cholinergic activation of a vagus nerve-to-spleen circuit alleviates experimental colitis.

H Ji, M F Rabbi, B Labis, V A Pavlov, K J Tracey, J E Ghia

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 1 pooled it
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 1 synthesis or guideline pooled it, 212 citations in OpenAlex.

  1. Mechanisms underlying the effect of acupuncture on cognitive improvement: a systematic review of animal studies.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2014
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. The spleen in ischaemic heart disease.Nature reviews. Cardiology · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

H JiDepartment of Immunology and Internal Medicine Section of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada.
M F RabbiDepartment of Immunology and Internal Medicine Section of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada.
B LabisDepartment of Immunology and Internal Medicine Section of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada.
V A PavlovCenter for Biomedical Science, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
K J TraceyCenter for Biomedical Science, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
J E Ghia1] Department of Immunology and Internal Medicine Section of Gastroenterology, University of Manitoba, Winnipeg, Manitoba, Canada [2] Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
University of Manitoba · CAFeinstein Institute for Medical Research · USMcMaster University · CA

Funding

Central cholinergic regulation of inflammationR01GM089807 · NIGMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI PAVLOV, VALENTIN ATANASSOV · 2011 to 2014
$1.1M
NIGMS NIH HHS 1R01GM089807NIGMS NIH HHS R01 GM089807
6 · The paper itself

Abstract

The cholinergic anti-inflammatory pathway is an efferent vagus nerve-based mechanism that regulates immune responses and cytokine production through α7 nicotinic acetylcholine receptor (α7nAChR) signaling. Decreased efferent vagus nerve activity is observed in inflammatory bowel disease. We determined whether central activation of this pathway alters inflammation in mice with colitis and the mediating role of a vagus nerve-to-spleen circuit and α7nAChR signaling. Two experimental models of colitis were used in C57BL/6 mice. Central cholinergic activation induced by the acetylcholinesterase inhibitor galantamine or a muscarinic acetylcholine receptor agonist treatments resulted in reduced mucosal inflammation associated with decreased major histocompatibility complex II level and pro-inflammatory cytokine secretion by splenic CD11c⁺ cells mediated by α7nAChR signaling. The cholinergic anti-inflammatory efficacy was abolished in mice with vagotomy, splenic neurectomy, or splenectomy. In conclusion, central cholinergic activation of a vagus nerve-to-spleen circuit controls intestinal inflammation and this regulation can be explored to develop novel therapeutic strategies.

Indexed as

Signal Transductionalpha7 Nicotinic Acetylcholine ReceptorAnimalsCholinesterase InhibitorsColitisCytokinesDisease Models, AnimalGalantamineLigandsMaleMiceReceptors, MuscarinicSeverity of Illness IndexSpleenVagus Nervealpha7 Nicotinic Acetylcholine ReceptorCholinesterase InhibitorsCytokinesGalantamineLigandsReceptors, Muscarinic

Identifiers

PMID23881354
PMCPMC3859808
OpenAlexW2036325748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.